Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036711 · ClinicalTrials.gov registry record
Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 249
- Enrollment target
NCT01036711 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 249 participants.
The verdict
NCT01036711 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
Study Summary
Background: \- Many cigarette smokers claim that smoking improves their ability to think and concentrate, and have reported problems in thinking and concentration after quitting smoking. Some research has indicated that nicotine can enhance certain aspects of attention and memory in humans. However, more research is needed to determine how nicotine affects different elements of the brain s ability to think, pay attention, respond to rewards, and make decisions. Researchers are interested in using functional magnetic resonance imaging (fMRI) to study the effects of nicotine on brain function and activity. Objectives: \- To determine the effects of nicotine on attentional and other thinking processes, including reward-seeking behavior. Eligibility: \- Individuals between 18 and 50 years of age who are either current smokers (10 or more cigarettes per day for at least 1 year) or nonsmokers. Design: * The study has four experiments. Each experiment requires two MRI scanning sessions and a training session. Participant can do one or all of the experiments. * Participants will receive training on the types of computerized tests that will be given during the active portion of the study. Participants will also fill out questionnaires on nicotine use and other alcohol and drug use, and provide breath and urine samples. * During the test sessions, participants will have fMRI scanning while performing up to four different sets of tasks that test attention, memory, concentration, reward-seeking behavior, and decision making. Smokers will wear a nicotine patch or placebo patch during the test sessions, but will not be told which patch they are receiving. The order of these sessions will be different for individual participants. * Participants will provide blood and urine samples throughout the research study for evaluation purposes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2002-09-17 |
| Est. Completion | 2012-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036711
The ClinicalTrials.gov registry entry for NCT01036711 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01036711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01036711 about?
NCT01036711 is a clinical study titled "Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI". Background: \- Many cigarette smokers claim that smoking improves their ability to think and concentrate, and have reported problems in thinking and concentration after quitting smoking. Some research has indicated that nicotine can enhance certain aspects of attention and memory in humans. However...
What is the current status of trial NCT01036711?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2002-09-17. Estimated completion is 2012-11-26.
Who is sponsoring clinical trial NCT01036711?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.